文献速递肿瘤 PET/CT骨显像与常规 SPECT

术前FDG PET/CT阳性对肿瘤性骨软化症术后复发的预后价值

Prognostic Value of Positive Presurgical FDG PET/CT in the Evaluation of Tumor-Induced Osteomalacia.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该回顾性研究纳入76例手术切除致病肿瘤的肿瘤性骨软化症(TIO)患者,术前均行18F-FDG与68Ga-DOTATATE PET/CT,随访5年。结果显示术前FDG PET/CT阳性者复发风险显著高于阴性者,提示其可用于预测术后复发。

要点

  • 术前FDG PET/CT阳性与TIO术后复发风险升高相关。
  • 68Ga-DOTATATE PET/CT可检出全部致病肿瘤,但仅部分FDG阳性。
  • 术前FDG阴性者术后复发概率很低。

核心结论

  • 术前FDG PET/CT阳性提示TIO手术切除后复发可能性增加。
  • 若68Ga-DOTATATE检出的致病肿瘤在FDG PET/CT上无高摄取,则复发概率很小。

研究设计与样本

  • 回顾性研究纳入76例因肿瘤导致骨软化症并接受手术切除的患者。
  • 所有患者术前均行18F-FDG和68Ga-DOTATATE PET/CT,并随访5年评估预后价值。

主要发现

  • 术前68Ga-DOTATATE PET/CT在全部76例中检出病灶,而FDG PET/CT仅25例阳性。
  • 术后随访中15例(19.7%)出现复发性低磷血症并再次出现症状。
  • 15例复发患者中11例(73.3%)在原切除肿瘤部位复发,4例因原发肿瘤恶性性质在其他部位复发。
  • 15例复发患者中14例术前FDG PET/CT阳性,阳性组复发率为56.0%(14/25)。
  • 仅1例复发患者术前FDG PET/CT阴性,阴性组复发率为1.9%(1/51),显著低于阳性组(P < 0.05)。

关键数值与推荐

  • 术前FDG PET/CT阳性组复发率为56.0%(14/25),阴性组为1.9%(1/51),差异有统计学意义(P < 0.05)。

临床怎么用

  • 对TIO患者术前可结合FDG PET/CT阳性结果评估术后复发风险。
  • FDG PET/CT阴性而68Ga-DOTATATE阳性的致病肿瘤,术后复发概率很低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

METHODS: Seventy-six patients who had surgically removed tumors that caused osteomalacia were included in this retrospective investigation. All patients underwent both 18F-FDG and 68Ga-DOTATATE PET/CT prior to surgery. The prognostic value of presurgical FDG PET/CT study was determined with 5-year follow-up. RESULTS: In the presurgical evaluation, 68Ga-DOTATATE detected lesions in all 76 patients. However, FDG PET/CT was positive in only 25 among all 76 patients. Following surgical removal of the causative tumor, all 76 patients had symptomatic relief and normalization of the serum phosphate level initially. However, 15 of 76 cases (19.7%) had recurrent hypophosphatemia and became symptomatic again during the follow-up. Among these 15 patients with recurrence, 11 (73.3%) had recurrent lesions at the original location of the resected causative tumors, whereas 4 were in other locations due to malignant nature of the primary tumor. Interestingly, 14 of these 15 patients with recurrent disease had positive presurgical FDG PET/CT findings with an incident ratio of 56.0% (14 of 25). In contrast, only 1 patient with recurrent disease had negative presurgical FDG PET/CT scan with an incident ratio of 1.9% (1 of 51), significantly less than the positive presurgical FDG PET/CT group (P < 0.05). CONCLUSIONS: A positive presurgical FDG PET/CT suggests increased likelihood for possible recurrence of TIO after surgical resection. In contrast, when a causative tumor detected by 68Ga-DOTATATE PET/CT does not have elevated activity on FDG PET/CT, the chance of recurrence is very small.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wang P, Zhang S, Huo L, et al. Prognostic Value of Positive Presurgical FDG PET/CT in the Evaluation of Tumor-Induced Osteomalacia. Clin Nucl Med. 2021. PMID: 33351512. doi:10.1097/RLU.0000000000003463

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。